Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Neurodegenerative diseases (NDDs) encompass numerous disorders affecting the nervous system’s structure and functions, primarily caused by protein aggregation, oxidative stress, and inflammation. These factors make a significant contribution to the progression of various NDDs. Curcumin (CUR), a natural bioactive compound known for its anti-inflammatory and antioxidant properties, has limited application because of its hydrophobicity. To address this issue, PEGylated coated magnetite nanoparticles (MNPs) were developed as efficient nanocarriers. These MNPs were synthesized using plant polyphenols from cocoa bean (Theobroma cacao) shell extract, coated with PEG, and then loaded with CUR at various concentrations. The nanomaterials were characterized using X-ray diffraction (XRD), Dynamic light scattering (DLS), zeta potential (ZP), FTIR, Transmission electron microscopy (TEM), selected-area electron diffraction (SAED), and vibrating sample magnetometer (VSM). The nanoparticles were found to be spherical, with diameters in the range of 10–19 nm. VSM analysis showed that the MNPs exhibited superparamagnetic behavior at room temperature. In vitro studies using ultraviolet (UV) spectrophotometry revealed rapid CUR drug loading within 3 h and total drug release of 57% over 48 h, indicating the potential of the MNPs as a neuroprotective agent. The cell viability associated with exposure to the nanoformulations was also assessed in human neuroblastoma cells (SH-SY5Y) using the MTT assay. In addition, the safety and anti-inflammatory properties of PEGylated MNPs–CUR were evaluated in LPS-induced murine macrophages (RAW 264.7). Cells exposed to the nanoparticles exhibited high viability, indicating their safety for human neuroblastoma cells, and the nanoparticles effectively reduced nitric oxide production in murine macrophages. These findings suggest that PEGylated MNPs–CUR possess significant potential as neuroprotective agents for brain-related diseases, given their biosafety and anti-inflammatory properties.
M. Tsakiri, I. Tsichlis, C. Zivko, et al. Lipidic nanoparticles, extracellular vesicles and hybrid platforms as advanced medicinal products: Future therapeutic prospects for neurodegenerative diseases. Pharmaceutics, 2024, 16(3): 350. https://doi.org/10.3390/pharmaceutics16030350
C. Mathieu, R.V. Pappu, J.P. Taylor. Beyond aggregation: Pathological phase transitions in neurodegenerative disease. Science, 2020, 370(6512): 56−60. https://doi.org/10.1126/science.abb8032
S. Tiwari, V. Atluri, A. Kaushik, et al. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine, 2019, 14: 5541−5554. https://doi.org/10.2147/ijn.s200490
T.A. Enache, A.M. Oliveira-Brett. Alzheimer’s disease amyloid beta peptides in vitro electrochemical oxidation. Bioelectrochemistry, 2017, 114: 13−23. https://doi.org/10.1016/j.bioelechem.2016.11.003
C. Tonda-Turo, N. Origlia, C. Mattu, et al. Current limitations in the treatment of Parkinson’s and Alzheimer’s diseases: State-of-the-art and future perspective of polymeric carriers. Current Medicinal Chemistry, 2019, 25(41): 5755−5771. https://doi.org/10.2174/0929867325666180221125759
S. Hewlings, D. Kalman. Curcumin: A review of its effects on human health. Foods, 2017, 6(10): 92. https://doi.org/10.3390/foods6100092
N. Kandezi, M. Mohammadi, M. Ghaffari, et al. Novel insight to neuroprotective potential of curcumin: A mechanistic review of possible involvement of mitochondrial biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF signaling pathways. International Journal of Molecular and Cellular Medicine, 2020, 9(1): 1−32. https://doi.org/10.22088/IJMCM.BUMS.9.1.1
H.Q. Lv, Y. Wang, X.T. Yang, et al. Application of curcumin nanoformulations in Alzheimer’s disease: Prevention, diagnosis and treatment. Nutritional Neuroscience, 2023, 26(8): 727−742. https://doi.org/10.1080/1028415x.2022.2084550
J. Jeevanandam, A. Barhoum, Y.S. Chan, et al. Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations. Beilstein Journal of Nanotechnology, 2018, 9: 1050−1074. https://doi.org/10.3762/bjnano.9.98
I. Khan, K. Saeed, I. Khan. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 2019, 12(7): 908−931. https://doi.org/10.1016/j.arabjc.2017.05.011
M.R. Ghazanfari, M. Kashefi, S.F. Shams, et al. Perspective of Fe3O4Nanoparticles role in biomedical applications. Biochemistry Research International, 2016, 2016: 7840161. https://doi.org/10.1155/2016/7840161
A. A. Hernández-Hernández, G. Aguirre-Álvarez, R. Cariño-Cortés, et al. Iron oxide nanoparticles: synthesis, functionalization, and applications in diagnosis and treatment of cancer. Chemical Papers, 2020, 74(11): 3809−3824. https://doi.org/10.1007/s11696-020-01229-8
Y.X. Liu, W.J. Zhu, D. Wu, et al. Electrochemical determination of dopamine in the presence of uric acid using palladium-loaded mesoporous Fe3O4 nanoparticles. Measurement, 2015, 60: 1−5. https://doi.org/10.1016/j.measurement.2014.09.067
N. Sher, M. Ahmed, N. Mushtaq, et al. Acetylcholinesterase activity in the brain of rats: Presence of an inhibitor of enzymatic activity in Heliotropium eichwaldi L. induced silver/gold allied bimetallic nanoparticles. Nano Biomedicine and Engineering, 2023, 15(3): 317−329. https://doi.org/10.26599/nbe.2023.9290034
Z. Ait Bachir, Y.K. Huang, M.Y. He, et al. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles. International Journal of Nanomedicine, 2018, 13: 5657−5671. https://doi.org/10.2147/ijn.s167443
J.S. Suk, Q.G. Xu, N. Kim, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews, 2016, 99: 28−51. https://doi.org/10.1016/j.addr.2015.09.012
G. Gahlawat, A.R. Choudhury. A review on the biosynthesis of metal and metal salt nanoparticles by microbes. RSC Advances, 2019, 9(23): 12944−12967. https://doi.org/10.1039/C8RA10483B
M.A. Martín, S. Ramos. Cocoa polyphenols in oxidative stress: Potential health implications. Journal of Functional Foods, 2016, 27: 570−588. https://doi.org/10.1016/j.jff.2016.10.008
M. Martín, S. Ramos, I. Cordero-Herrero, et al. Cocoa phenolic extract protects pancreatic beta cells against oxidative stress. Nutrients, 2013, 5(8): 2955−2968. https://doi.org/10.3390/nu5082955
M. Akrami, M. Khoobi, M. Khalilvand-Sedagheh, et al. Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment. RSC Adv, 2015, 5: 88096−88107. https://doi.org/10.1039/C5RA13838H
I.A. Walbi, M.Z. Ahmad, J. Ahmad, et al. Development of a curcumin-loaded lecithin/chitosan nanoparticle utilizing a Box-Behnken design of experiment: Formulation design and influence of process parameters. Polymers, 2022, 14(18): 3758. https://doi.org/10.3390/polym14183758
Y.J. Lv, J.J. Li, H.L. Chen, et al. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. International Journal of Nanomedicine, 2017, 12: 4361−4370. https://doi.org/10.2147/ijn.s135626
A. van Tonder, A.M. Joubert, A.D. Cromarty. Limitations of the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Research Notes, 2015, 8(1): 47. https://doi.org/10.1186/s13104-015-1000-8
W.M. Xue, Y.Y. Liu, N. Zhang, et al. Effects of core size and PEG coating layer of iron oxide nanoparticles on the distribution and metabolism in mice. International Journal of Nanomedicine, 2018, 13: 5719−5731. https://doi.org/10.2147/ijn.s165451
M.F. Tai, C.W. Lai, S.B. Abdul Hamid. Facile synthesis polyethylene glycol coated magnetite nanoparticles for high colloidal stability. Journal of Nanomaterials, 2016, 2016: 8612505. https://doi.org/10.1155/2016/8612505
S. Arsalani, Y. Hadadian, E.E. Mazon, et al. Uniform size PEGylated iron oxide nanoparticles as a potential theranostic agent synthesized by a simple optimized coprecipitation route. Journal of Magnetism and Magnetic Materials, 2022, 564: 170091. https://doi.org/10.1016/j.jmmm.2022.170091
M. Szekeres, I. Tóth, E. Illés, et al. Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications. International Journal of Molecular Sciences, 2013, 14(7): 14550−14574. https://doi.org/10.3390/ijms140714550
M. Afrouz, F. Ahmadi-Nouraldinvand, S.G. Elias, et al. Green synthesis of spermine coated iron nanoparticles and its effect on biochemical properties of Rosmarinus officinalis. Scientific Reports, 2023, 13(1): 775. https://doi.org/10.1038/s41598-023-27844-5
N.D. Kandpal, N. Sah, R. Loshali, et al. Co-precipitation method of synthesis and characterization of iron oxide nanoparticles. Journal of Scientific & Industrial Research, 2014, 73(2): 87−90.
H.L. Ma, X.R. Qi, Y. Maitani, et al. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. International Journal of Pharmaceutics, 2007, 333(1-2): 177−186. https://doi.org/10.1016/j.ijpharm.2006.10.006
K.O. Saygi, E. Cacan. Antioxidant and cytotoxic activities of silver nanoparticles synthesized using Tilia cordata flowers extract. Materials Today Communications, 2021, 27: 102316. https://doi.org/10.1016/j.mtcomm.2021.102316
W.J. Chen, Y.T. Xu, D.C. Yang, et al. Preparation of liposomes coated superparamagnetic iron oxide nanoparticles for targeting and imaging brain glioma. Nano Biomedicine and Engineering, 2022, 14(1): 71−80. https://doi.org/10.5101/nbe.v14i1.p71-80
A.B. Gorospe, S.C. Buenviaje, Y.G. Edañol, et al. One-step co-precipitation synthesis of water-stable poly(ethylene glycol)-coated magnetite nanoparticles. Journal of Physics: Conference Series, 2019, 1191: 012059. https://doi.org/10.1088/1742-6596/1191/1/012059
B. Khatun, N. Banik, A. Hussain, et al. Genipin crosslinked curcumin loaded chitosan/montmorillonite K-10 (MMT) nanoparticles for controlled drug delivery applications. Journal of Microencapsulation, 2018, 35(5): 439−453. https://doi.org/10.1080/02652048.2018.1524524
D. Farhanian, G. De Crescenzo, J.R. Tavares. Large-scale encapsulation of magnetic iron oxide nanoparticles via syngas photo-initiated chemical vapor deposition. Scientific Reports, 2018, 8: 12223. https://doi.org/10.1038/s41598-018-30802-1
S.A. Kulkarni, S.S. Feng. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharmaceutical Research, 2013, 30(10): 2512−2522. https://doi.org/10.1007/s11095-012-0958-3
L. Ribovski, N.M. Hamelmann, J.M.J. Paulusse. Polymeric nanoparticles properties and brain delivery. Pharmaceutics, 2021, 13(12): 2045. https://doi.org/10.3390/pharmaceutics13122045
S. Ohta, E. Kikuchi, A. Ishijima, et al. Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening. Scientific Reports, 2020, 10: 18220. https://doi.org/10.1038/s41598-020-75253-9
P.B. Shete, R.M. Patil, R.S. Ningthoujam, et al. Magnetic core-shell structures for magnetic fluid hyperthermia therapy application. New Journal of Chemistry, 2013, 37(11): 3784−3792. https://doi.org/10.1039/c3nj00862b
M. Bañobre-López, A. Teijeiro, J. Rivas. Magnetic nanoparticle-based hyperthermia for cancer treatment. Reports of Practical Oncology and Radiotherapy, 2013, 18(6): 397−400. https://doi.org/10.1016/j.rpor.2013.09.011
M. Nadeem, M. Ahmad, M.S. Akhtar, et al. Magnetic properties of polyvinyl alcohol and doxorubicine loaded iron oxide nanoparticles for anticancer drug delivery applications. PLoS One, 2016, 11(6): e0158084. https://doi.org/10.1371/journal.pone.0158084
Z. Özcan, A.B. Hazar Yoruç. Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: Synthesis, characterization, and in vitro release study. Beilstein Journal of Nanotechnology, 2024, 15: 256−269. https://doi.org/10.3762/bjnano.15.24
J. Shen, J.T. Zhang, W.T. Wu, et al. Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels, 2023, 9(9): 762. https://doi.org/10.3390/gels9090762
Z.F. Liu, M. Chiu, W. Jiang, et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemotherapy and Pharmacology, 2012, 69(3): 679−689. https://doi.org/10.1007/s00280-011-1749-y
A.V. Angarita, A. Umaña-Perez, L.D. Perez. Enhancing the performance of PEG- b-PCL-based nanocarriers for curcumin through its conjugation with lipophilic biomolecules. Journal of Bioactive and Compatible Polymers, 2020, 35(4-5): 399−413. https://doi.org/10.1177/0883911520944416
W. Arozal, M. Louisa, D. Rahmat, et al. Development, characterization and pharmacokinetic profile of chitosan-sodium tripolyphosphate nanoparticles based drug delivery systems for curcumin. Advanced Pharmaceutical Bulletin, 2020, 11(1): 77−85. https://doi.org/10.34172/apb.2021.008
A.S. Joshi, H.S. Patel, V.S. Belgamwar, et al. Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation. Journal of Materials Science Materials in Medicine, 2012, 23: 2163−2175. https://doi.org/10.1007/s10856-012-4702-7
H.P. Le Khanh, Á. Haimhoffer, D. Nemes, et al. Effect of molecular weight on the dissolution profiles of PEG solid dispersions containing ketoprofen. Polymers, 2023, 15(7): 1758. https://doi.org/10.3390/polym15071758
A.A. D’souza, R. Shegokar. Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications. Expert Opinion on Drug Delivery, 2016, 13(9): 1257−1275. https://doi.org/10.1080/17425247.2016.1182485
A. Rahma, M.M. Munir, A. Khairurrijal, et al. Intermolecular interactions and the release pattern of electrospun curcumin-polyvinyl(pyrrolidone) fiber. Biological and Pharmaceuical Bulletin, 2016, 39(2): 163−173. https://doi.org/10.1248/bpb.b15-00391
H. Rachmawati, Y.L. Yanda, A. Rahma, et al. Curcumin-loaded PLA nanoparticles: formulation and physical evaluation. Scientia Pharmaceutica, 2016, 84(1): 191−202. https://doi.org/10.3797/scipharm.ISP.2015.10
S. Bisht, G. Feldmann, S. Soni, et al. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): A novel strategy for human cancer therapy. Journal of Nanobiotechnology, 2007, 5(1): 3. https://doi.org/10.1186/1477-3155-5-3
M.L. Laracuente, M.H. Yu, K.J. McHugh. Zero-order drug delivery: State of the art and future prospects. Journal of Controlled Release, 2020, 327: 834−856. https://doi.org/10.1016/j.jconrel.2020.09.020
D. Wojcik-Pastuszka, J. Krzak, B. Macikowski, et al. Evaluation of the release kinetics of a pharmacologically active substance from model intra-articular implants replacing the cruciate ligaments of the knee. Materials, 2019, 12(8): 1202. https://doi.org/10.3390/ma12081202
D.R. Paul. Elaborations on the Higuchi model for drug delivery. International Journal of Pharmceutics, 2011, 418(1): 13−17. https://doi.org/10.1016/j.ijpharm.2010.10.037
P. Trucillo. Drug carriers: A review on the most used mathematical models for drug release. Processes, 2022, 10(6): 1094. https://doi.org/10.3390/pr10061094
O. Sreekanth Reddy, M.C.S. Subha, T. Jithendra, et al. Curcumin encapsulated dual cross linked sodium alginate/montmorillonite polymeric composite beads for controlled drug delivery. Journal of Pharmaceutical Analysis, 2021, 11(2): 191−199. https://doi.org/10.1016/j.jpha.2020.07.002
H.H. Gustafson, D. Holt-Casper, D.W. Grainger, et al. Nanoparticle uptake: The phagocyte problem. Nano Today, 2015, 10(4): 487−510. https://doi.org/10.1016/j.nantod.2015.06.006
M.A. Solaiman, M.A. Ali, N.M. Abdel-Moein, et al. Synthesis of Ag-NPs developed by green-chemically method and evaluation of antioxidant activities and anti-inflammatory of synthesized nanoparticles against LPS-induced NO in RAW 264.7 macrophages. Biocatalysis and Agricultural Biotechnology, 2020, 29: 101832. https://doi.org/10.1016/j.bcab.2020.101832
E.H. Lee, Y.J. Cho. Responses of inflammation signaling pathway by saucerneol D from elicitor-treated Saururus chinensis on pro-inflammatory responses in LPS-stimulated Raw 264.7 cell. Applied Biological Chemistry, 2021, 64(1): 24. https://doi.org/10.1186/s13765-020-00585-z
Z.M. Liu, W.Q. Li, F. Wang, et al. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. Nanoscale, 2012, 4(22): 7135−7142. https://doi.org/10.1039/C2NR31355C
P. Singh, H. Singh, S. Ahn, et al. Pharmacological importance, characterization and applications of gold and silver nanoparticles synthesized by Panax ginseng fresh leaves. Artificial Cells, Nanomedicine, and Biotechnology, 2017, 45(7): 1415−1424. https://doi.org/10.1080/21691401.2016.1243547
A. Adamu, S. Li, F.K. Gao, et al. The role of neuroinflammation in neurodegenerative diseases: Current understanding and future therapeutic targets. Frontiers in Aging Neuroscience, 2024, 16: 1347987. https://doi.org/10.3389/fnagi.2024.1347987
R. Orihuela, C.A. McPherson, G.J. Harry. Microglial M1/M2 polarization and metabolic states. British Journal of Pharmacology, 2016, 173(4): 649−665. https://doi.org/10.1111/bph.13139
A.M. Alnuqaydan, A.G. Almutary, M. Azam, et al. Phytantriol-based berberine-loaded liquid crystalline nanoparticles attenuate inflammation and oxidative stress in lipopolysaccharide-induced RAW264.7 macrophages. Nanomaterials, 2022, 12(23): 4312. https://doi.org/10.3390/nano12234312
E. Jones, I.M. Adcock, B.Y. Ahmed, et al. Modulation of LPS stimulated NF-kappaB mediated nitric Oxide Production by PKCε and JAK2 in RAW macrophages. Journal of Inflammation, 2007, 4(1): 23. https://doi.org/10.1186/1476-9255-4-23
Y.J. Kim, W. Park. Anti-inflammatory effect of quercetin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid. Molecules, 2016, 21(4): 450. https://doi.org/10.3390/molecules21040450
T. Li, F. Li, X.Y. Liu, et al. Synergistic anti-inflammatory effects of quercetin and catechin via inhibiting activation of TLR4–MyD88-mediated NF-κB and MAPK signaling pathways. Phytotherapy Research, 2019, 33(3): 756−767. https://doi.org/10.1002/ptr.6268
Y. Peng, S. Chu, Y. Yang, et al. Neuroinflammatory in vitro cell culture models and the potential applications for neurological disorders. Frontiers in Pharmacology, 2021, 12: 671734. https://doi.org/10.3389/fphar.2021.671734
L. Strother, G.B. Miles, A.R. Holiday, et al. Long-term culture of SH-SY5Y neuroblastoma cells in the absence of neurotrophins: A novel model of neuronal ageing. Journal of Neuroscience Methods, 2021, 362: 109301. https://doi.org/10.1016/j.jneumeth.2021.109301
T. Toimela, H. Mäenpää, M. Mannerström, et al. Development of an in vitro blood–brain barrier model—Cytotoxicity of mercury and aluminum. Toxicology and Applied Pharmacology, 2004, 195(1): 73−82. https://doi.org/10.1016/j.taap.2003.11.002
M.E. Piersimoni, X. Teng, A.E.G. Cass, et al. Antioxidant lipoic acid ligand-shell gold nanoconjugates against oxidative stress caused by α-synuclein aggregates. Nanoscale Advances, 2020, 2(12): 5666−5681. https://doi.org/10.1039/D0NA00688B
N. Ismail, M. Ismail, M.U. Imam, et al. Mechanistic basis for protection of differentiated SH-SY5Y cells by oryzanol-rich fraction against hydrogen peroxide-induced neurotoxicity. BMC Complementary and Alternative Medicine, 2014, 14(1): 467. https://doi.org/10.1186/1472-6882-14-467
J. Zargan, M. Sajad, S. Umar, et al. Scorpion ( Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells. Molecular and Cellular Biochemistry, 2011, 348(1-2): 173−181. https://doi.org/10.1007/s11010-010-0652-x
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.